Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Skyhawk Therapeutics, Inc.

Clinical trials sponsored by Skyhawk Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill aims to tame Huntington's disease by targeting toxic proteins Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 2

New pill aims to tackle Huntington's at its source

Disease control Recruiting now

This clinical trial tests an oral drug called SKY-0515 in 400 adults with Huntington's disease. The goal is to see if it can lower harmful proteins linked to the disease and improve symptoms like movement and thinking. Participants take the drug or a placebo daily for 18 months.

Phase 2/3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC